Congo vs Guatemala: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Congo
85.0%
in 2025
Guatemala
85.0%
in 2025
Congo rank
96th
Guatemala rank
96th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Congo
- Guatemala
How they compare
Congo currently reports 85.0% against 85.0% in Guatemala, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Guatemala ahead.
Congo ranks 96th and Guatemala ranks 96th of 194 countries.
Guatemala has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Congo | Guatemala | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 53.4% | 57.9% | 4.5% | Guatemala |
| 2020s | 77.5% | 87.7% | 10.2% | Guatemala |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Congo or Guatemala?
- Congo, at 85.0% against 85.0% in Guatemala as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Congo and Guatemala?
- 0.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Guatemala?
- 18 years are reported by both, from 2008 to 2025.
- How do Congo and Guatemala rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Congo ranks 96th and Guatemala ranks 96th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.